Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes
作者： Heike A. Bischoff-Ferrari
DOI: 10.1007/978-0-387-77574-6_5
关键词:
摘要: Recent evidence suggests that higher vitamin D intakes beyond current recommendations may be associated with better health outcomes. In this chapter, is summarized from different studies evaluate threshold levels for serum 25(OH)D in relation to bone mineral density (BMD), lower extremity function, dental health, risk of falls, admission nursing home, fractures, cancer prevention and incident hypertension. For all endpoints, the most advantageous appeared at least 75 nmol/l (30 ng/ml) prevention, desirable are between 90-120 (36-48 ng/ml). An intake no less than 1000 IU (25 mcg) D3 (cholecalciferol) per day adults bring 50% population up nmol/l. Thus, doses needed individuals into desired range. While estimates suggest 2000 successfully safely achieve goal, implications or total adult need addressed future studies.
springer.com
uzh.ch
sci-hub.se 参考文章(150)
Bess Dawson-Hughes, Impact of Vitamin D and Calcium on Bone and Mineral Metabolism in Older Adults Springer, Boston, MA. pp. 175- 183 ,(2002) , 10.1007/978-1-4615-0937-0_17
O. H. Sørensen, BI. Lund, B. Saltin, BJ. Lund, R. B. Andersen, L. Hjorth, F. Melsen, L. Mosekilde, Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clinical Science. ,vol. 56, pp. 157- 161 ,(1979) , 10.1042/CS0560157
Roger Bouillon, Terry Moody, Michael Sporn, J. Carl Barrett, Anthony W. Norman, NIH deltanoids meeting on Vitamin D and cancer. Conclusion and strategic options. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 97, pp. 3- 5 ,(2005) , 10.1016/J.JSBMB.2005.06.016
RECORD Trial Group, None, Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. The Lancet. ,vol. 365, pp. 1621- 1628 ,(2005) , 10.1016/S0140-6736(05)63013-9
Richard J Wood, Laurie Tchack, Shveta Taparia, 1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line BMC Physiology. ,vol. 1, pp. 11- 11 ,(2001) , 10.1186/1472-6793-1-11
Laurent Dukas, Heike A. Bischoff, Lyn S. Lindpaintner, Erich Schacht, Dagmar Birkner-binder, Thomas N. Damm, Beat Thalmann, Hannes B. Stähelin, Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. Journal of the American Geriatrics Society. ,vol. 52, pp. 230- 236 ,(2004) , 10.1111/J.1532-5415.2004.52060.X
R U Simpson, G A Thomas, A J Arnold, Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. Journal of Biological Chemistry. ,vol. 260, pp. 8882- 8891 ,(1985) , 10.1016/S0021-9258(17)39433-4
Kerry E. Broe, Tai C. Chen, Janice Weinberg, Heike A. Bischoff-Ferrari, Michael F. Holick, Douglas P. Kiel, A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study Journal of the American Geriatrics Society. ,vol. 55, pp. 234- 239 ,(2007) , 10.1111/J.1532-5415.2007.01048.X
Ellen D. Burgess, Ralph G. Hawkins, Mamoru Watanabe, Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. American Journal of Hypertension. ,vol. 3, pp. 903- 905 ,(1990) , 10.1093/AJH/3.12.903
Lars Lind, Bo Wengle, Leif Wide, Sverker Ljunghall, Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. American Journal of Hypertension. ,vol. 2, pp. 20- 25 ,(1989) , 10.1093/AJH/2.1.20